DIR Return Create A Forum - Home
---------------------------------------------------------
Camelot Fantasies
HTML https://castleknights.createaforum.com
---------------------------------------------------------
*****************************************************
DIR Return to: Stocks Universe
*****************************************************
#Post#: 52829--------------------------------------------------
Own The Float Global Center
By: Clay Death Date: December 23, 2016, 10:27 am
---------------------------------------------------------
[move][font=comic sans ms]Welcome To Own The Float Global Center
Welcome To Own The Float Global Center
Welcome To Own The Float Global Center[/font][/move]
#Post#: 52886--------------------------------------------------
Re: Own The Float Global Center
By: Clay Death Date: December 23, 2016, 10:24 pm
---------------------------------------------------------
Welcome to Camelot.
#Post#: 52962--------------------------------------------------
Re: Own The Float Global Center
By: Clay Death Date: December 24, 2016, 9:49 pm
---------------------------------------------------------
HTML http://ownthefloat.com/index.php/2016/12/24/owcp-2016-year-end-recap/
#Post#: 52963--------------------------------------------------
Re: Own The Float Global Center
By: Clay Death Date: December 24, 2016, 9:50 pm
---------------------------------------------------------
OWCP: 2016 Year End Recap
December 24, 2016, By OwnTheFloat | Leave a reply
As more investors become aware of OWCP, I thought it’d be a good
idea to write up a year end recap. After all, it’s been the
opinion of virtually every shareholder (not flippers) that the
BIG gains are coming in 2017. I really don’t know how anybody
could dispute that. Why wouldn’t a Cannabis Pharmaceutical
company have a rise in PPS after they start generating revenue?
There are a handful of other Marijuana stocks that have seen
tremendous gains and are still sitting at a really high (and
overvalued) Market Value due to the hype they’ve received from
certain ‘industry celebrities’ (via their own websites and
Twitter).
Back on October 23rd, 2016, I e-mailed a certain ‘industry
celeb’ and asked why OWCP wasn’t on his list. His reply was,
“Lol.. I could give you 50 reasons”. I said, “OK? I’d love to
hear a couple.” He then replied, “I would start by looking at
their debt holders.”
After having just read the latest 8K, I was confused. So, I
pointed him to the latest 8-K that talked about no convertible
debt whatsoever and the $300,000 non-interest bearing loan from
MedMar.
His response, “Congrats. It’s going up like a rocket. Enjoy the
profit.”
My conclusion: He didn’t really have anything negative to say
after all. I will NOT be surprised if he comes around later on
in 2017. Again, why WOULDN’T he — or anyone else for that
matter?
Why am I so confident in OWCP? Here are 16 reasons from 2016!
They’re OTC QB, not Pink Sheets. If you don’t know why that
matters, read the requirements to being OTC QB directly from
OTCmarkets.com. It’s a big step towards showing you’re a legit
company not out to simply sell shares and line the Executives
pockets.
They only have 135M Outstanding Shares, not 2.3 BILLION like
other highly pumped Marijuana stocks (which, for some insane
reason, have Market Values beyond $100M as of writing this Blog
— despite having virtually no revenue and multi-million dollar
losses!)
They’re not pushing out “fluff” PRs all the time. Instead, OWCP
has been updating shareholders mostly via 8K’s. These 8K’s
contain pretty solid updates too in regards to new investments,
distribution deals, etc. Click here to see the list of 8K’s
released.
No Toxic Debt! A lot of OTC companies can only obtain financing
through Convertible Notes, which are often referred to as Toxic
Loans — because the debt holder sells shares at whatever level
they can to get paid back. It’s hard for a stock to surge when
someone is cashing in on the Bid for weeks straight. You can
read the FORM 8-K yourself. They talk about $300,000 of
NON-INTEREST BEARING loan and specifically point out “Registrant
has no convertible debt outstanding whatsoever.” That’s huge.
Real Doctors doing actual research and clinical trials in
Israel, a place considered to be the Medical Marijuana Capital
of the World. (See this report from CNN’s Dr. Sanjay Gupta — a
YouTube video, which I had purposely start at 35:08 from this
link.)
ClinicalTrials.gov lists OWCP’s “Study Record”, proving there
really is an ongoing clinical trial of their Psoriasis Cream.
This is dated the end of November.
March 29th — They completed in-vitro testing on its formulation
for multiple myeloma and is preparing to begin pre-clinical
safety and efficacy studies on mice.
They’re working with Emilia Cosmetics, one of Israel’s largest
private label cosmetics manufacturers, to develop the Psoriasis
cream (which should launch in Q2 of 2017). By the way, some of
Emilia’s clients include: Walmart, KMART, Walgreens, TEVA, Rite
Aid, etc.
September 30th — They announce a $300,000 (royalty) deal with
MedMar to have product distributed in the USA.
October 11th — They announced they’re in the Final Phase for
Testing their Psoriasis Cream.
October 20th — They announced that they’ve completed development
of a Medical Cannabis Sublingual Tablet — a smoke-free
alternative for those who cannot or don’t want to smoke.
November 3rd — They announce a Joint Venture and Private
Placement of $300,000 with Michepro Holding Ltd. Michepro will
promote, market, sell, and distribute OWCP products throughout
Europe (for a 25% cut). and also allows Michepro to buy more
shares at as much as $0.40/share in the future. (What a
frickin’ steal! It’s MY OPINION, but I can just about guarantee
OWCP shares will be worth quite a bit more than $0.40 by that
point in time.)
Industry EXPERT, Jeffrey Friedland, becomes an Advisory Board
Member. This man knows the Marijuana industry. He’s actually
the author of: “Marijuana: The World’s Most Misunderstood Plant“
They have signed three research collaboration agreements with
Sheba Academic Medical Center, the largest hospital in Israel
and in the Middle East.
They have filed eight provisional patents with the United States
Patent and Regulatory Office (USPTO), all related to its line of
activity related to cannabis-based medical products.
Though it didn’t take place in 2016, it’s still huge. TEVA, a
115 year old pharmaceutical company with over $20B in revenue,
made an offer to purchase OWCP’s patents! This leads me to
believe there will be future offers as OWCP continues to advance
their research and get closer to shipping products worldwide!
That’s a good start, right? There are so many positive signs
that OWCP is, in fact, going to be a multi-dollar (per share)
stock in 2017. It would be mind boggling if they don’t. I’ve
made previous comparison posts showing why OWCP is so much
better than a handful of other over-hyped Marijuana stocks. If
OWCP simply caught up to the inflated values of those other
guys, we’d be closer to $1.00 per share.
It’s fine though. Most of us who can tolerate holding shares in
a company for more than 30 days see the potential here. I’m
confident a majority of OWCP shareholders have owned shares for
beyond 90 days and will continue to own those shares for another
3 – 6 months. Some will start to cash out and take BIG profits
to pay for life’s many expenses, but, even they will regret not
waiting another 6 months. (That’s been my problem. I’m going
to be ridiculously giddy every day I see my Scottrade portfolio
over $100,000 – considering I started with a fraction of that.
But, I’ll need to learn patience! $1,000,000 will be 10X
sweeter than $100,000.)
Reminder: This blog contains facts linked to verifiable news
sources. The only speculation you need to be aware of is what
future share prices will be. That’s why YOU must decide when to
buy, sell, or hold. Let the DD be your guide.
#Post#: 56256--------------------------------------------------
Re: Own The Float Global Center
By: Divine Metamorphoses Date: February 8, 2017, 11:06 pm
---------------------------------------------------------
Cannibis
*****************************************************